Approaches, Challenges, and Advances in Metabolism of New Synthetic Cannabinoids and Identification of Optimal Urinary Marker Metabolites.
作者： X Diao , MA Huestis
DOI: 10.1002/CPT.534
关键词: Pharmacology 、 Urine 、 Hepatocyte 、 Synthetic cannabinoids 、 Biochemistry 、 Urinary system 、 Metabolism 、 Identification (biology) 、 Biology
摘要: … mass spectrometry data for identifying urinary SC metabolites. The CDM scientists … urinary metabolites by high resolution mass spectrometry, comparison to authentic urine metabolite …
sci-hub.se 
researchgate.net 参考文章(70)
Nahoko Uchiyama, Kazuhiro Asakawa, Ruri Kikura-Hanajiri, Taizo Tsutsumi, Takashi Hakamatsuka, A new pyrazole-carboxamide type synthetic cannabinoid AB-CHFUPYCA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole-5- carboxamide) identified in illegal products Forensic Toxicology. ,vol. 33, pp. 367- 373 ,(2015) , 10.1007/S11419-015-0283-8
Nik De Brabanter, Simone Esposito, Eva Tudela, Leen Lootens, Philip Meuleman, Geert Leroux-Roels, Koen Deventer, Peter Van Eenoo, In vivo
and in vitro
metabolism of the synthetic cannabinoid JWH-200 Rapid Communications in Mass Spectrometry. ,vol. 27, pp. 2115- 2126 ,(2013) , 10.1002/RCM.6673
Niels Bjerre Holm, Anders Just Pedersen, Petur Weihe Dalsgaard, Kristian Linnet, Metabolites of 5F‐AKB‐48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high‐resolution mass spectrometry Drug Testing and Analysis. ,vol. 7, pp. 199- 206 ,(2015) , 10.1002/DTA.1663
Tim Sobolevsky, Ilya Prasolov, Grigory Rodchenkov, Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids Drug Testing and Analysis. ,vol. 4, pp. 745- 753 ,(2012) , 10.1002/DTA.1418
Melanie Hutter, Bjoern Moosmann, Stefan Kneisel, Volker Auwärter, Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM‐2201 regarding its chemistry and metabolism Journal of Mass Spectrometry. ,vol. 48, pp. 885- 894 ,(2013) , 10.1002/JMS.3229
Monica J. Barratt, Vince Cakic, Simon Lenton, Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review. ,vol. 32, pp. 141- 146 ,(2013) , 10.1111/J.1465-3362.2012.00519.X
Cen Xie, Jialan Zhou, Zitao Guo, Xingxing Diao, Zhiwei Gao, Dafang Zhong, Haoyuan Jiang, Lijia Zhang, Xiaoyan Chen, Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients. British Journal of Pharmacology. ,vol. 168, pp. 1687- 1706 ,(2013) , 10.1111/BPH.12047
Ruri Kikura-Hanajiri, Nahoko Uchiyama Maiko Kawamura, Yukihiro Goda, Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan Drug Testing and Analysis. ,vol. 6, pp. 832- 839 ,(2014) , 10.1002/DTA.1584
Lei Men, Hongli Lin, Yunli Zhao, Hui Liu, Mingjing Yang, Ronghua Fan, Pei Wang, Xing Tang, Zhiguo Yu, Metabolism of TM-2, a potential antitumor drug, in rats by using LC-MS. Journal of Separation Science. ,vol. 37, pp. 625- 629 ,(2014) , 10.1002/JSSC.201301251
Ann M. Kemp, Molly S. Clark, Thomas Dobbs, Robert Galli, Justin Sherman, Robert Cox, Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice The American Journal of Medicine. ,vol. 129, pp. 240- 244 ,(2016) , 10.1016/J.AMJMED.2015.10.008